These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27639740)

  • 41. Late Strut Fracture Within a Partially Resorbed Bioresorbable Vascular Scaffold: A Possible Cause of Late Scaffold Thrombosis and Acute Coronary Syndrome.
    Asrar Ul Haq M; Erickson M; Rankin J; Whelan A
    Heart Lung Circ; 2017 Apr; 26(4):e26-e28. PubMed ID: 27884634
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bioresorbable vascular scaffolds for small vessels coronary disease: The BVS-save registry.
    Latini RA; Granata F; Ielasi A; Varricchio A; Moscarella E; Tespili M; Cortese B
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):380-7. PubMed ID: 27038332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immediate, acute, and subacute thrombosis due to incomplete expansion of bioresorbable scaffolds.
    Gori T; Schulz E; Münzel T
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1194-5. PubMed ID: 25240537
    [No Abstract]   [Full Text] [Related]  

  • 45. Novel 3-Dimensional Vessel and Scaffold Reconstruction Methodology for the Assessment of Strut-Level Wall Shear Stress After Deployment of Bioresorbable Vascular Scaffolds From the ABSORB III Imaging Substudy.
    Gogas BD; Yang B; Piccinelli M; Giddens DP; King SB; Kereiakes DJ; Ellis SG; Stone GW; Veneziani A; Samady H
    JACC Cardiovasc Interv; 2016 Mar; 9(5):501-3. PubMed ID: 26965940
    [No Abstract]   [Full Text] [Related]  

  • 46. Bioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure.
    Tanaka A; Jabbour RJ; Latib A; Colombo A
    Catheter Cardiovasc Interv; 2016 Nov; 88(S1):10-20. PubMed ID: 27797460
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Late stent thrombosis after the use of a bioresorbable vascular scaffold for the treatment of in-stent restenosis.
    Lee WC; Fang HY; Fang CY
    Coron Artery Dis; 2016 Dec; 27(8):709-710. PubMed ID: 27379437
    [No Abstract]   [Full Text] [Related]  

  • 48. Self-correction property a novel feature of bioresorbable coronary scaffolds.
    Diletti R; Ligthart JM; Ramdhan R; Van Mieghem NM
    Int J Cardiol; 2016 Jul; 214():417-8. PubMed ID: 27088402
    [No Abstract]   [Full Text] [Related]  

  • 49. 1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries.
    Tamburino C; Capranzano P; Gori T; Latib A; Lesiak M; Nef H; Caramanno G; Naber C; Mehilli J; Di Mario C; Sabaté M; Münzel T; Colombo A; Araszkiewicz A; Wiebe J; Geraci S; Jensen C; Mattesini A; Brugaletta S; Capodanno D
    JACC Cardiovasc Interv; 2016 Mar; 9(5):440-9. PubMed ID: 26875648
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical utility of optical coherence tomography (OCT) in the optimisation of Absorb bioresorbable vascular scaffold deployment during percutaneous coronary intervention.
    Allahwala UK; Cockburn JA; Shaw E; Figtree GA; Hansen PS; Bhindi R
    EuroIntervention; 2015 Feb; 10(10):1154-9. PubMed ID: 24647105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immediate and long-term clinical performance of bioresorbable vascular scaffolds in a real world population.
    Maggio S; Zanetti C; Pesarini G; Zivelonghi C; Piccoli A; Gambaro A; Scarsini R; Cuman M; Vassanelli C; Ribichini F
    Minerva Cardioangiol; 2016 Aug; 64(4):404-10. PubMed ID: 26963445
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical outcomes following target lesion revascularization for bioresorbable scaffold failure.
    Tanaka A; Ruparelia N; Kawamoto H; Sticchi A; Figini F; Carlino M; Chieffo A; Montorfano M; Latib A; Colombo A
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):832-6. PubMed ID: 26331577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel.
    Naganuma T; Latib A; Ielasi A; Panoulas VF; Sato K; Miyazaki T; Colombo A
    Int J Cardiol; 2014 Apr; 172(3):618-9. PubMed ID: 24495653
    [No Abstract]   [Full Text] [Related]  

  • 54. Imaging and functional assessment of bioresorbable scaffolds.
    Pighi M; Tanguay JF; L'allier PL
    Minerva Cardioangiol; 2016 Aug; 64(4):442-61. PubMed ID: 27195663
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Very late metallic stent malapposition and in-stent restenosis treated with a bioresorbable scaffold: a novel alternative for an old problem.
    Foin N; Lee R; Wong P; Low AF
    EuroIntervention; 2015 Aug; 11(4):e1. PubMed ID: 26298237
    [No Abstract]   [Full Text] [Related]  

  • 56. Very Late Scaffold Thrombosis Due to Insufficient Strut Apposition.
    Meincke F; Spangenberg T; Heeger CH; Bergmann MW; Kuck KH; Ghanem A
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1768-9. PubMed ID: 26476613
    [No Abstract]   [Full Text] [Related]  

  • 57. A very late thrombosis in a bioresorbable vascular scaffold.
    Giacchi M; Pedrazzini G; Moccetti T; Moccetti M
    EuroIntervention; 2015 Nov; 11(7):e1. PubMed ID: 26603865
    [No Abstract]   [Full Text] [Related]  

  • 58. [Decision-making while implantation of biodegradable vascular scaffolds ABSORB based on methods of intravascular visualization].
    Buzaev IV; Plechev VV; Nikolaeva IE; Zagitov IG; Oleĭnik BA
    Angiol Sosud Khir; 2016; 22(3):54-8. PubMed ID: 27626250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II).
    Ishibashi Y; Nakatani S; Sotomi Y; Suwannasom P; Grundeken MJ; Garcia-Garcia HM; Bartorelli AL; Whitbourn R; Chevalier B; Abizaid A; Ormiston JA; Rapoza RJ; Veldhof S; Onuma Y; Serruys PW
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1715-26. PubMed ID: 26585622
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current status of bioresorbable scaffolds in the treatment of coronary artery disease.
    Wiebe J; Nef HM; Hamm CW
    J Am Coll Cardiol; 2014 Dec; 64(23):2541-51. PubMed ID: 25500240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.